• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国首次诊断为前列腺癌患者的临床特征变化:一家三级中心报告的 10 年趋势。

Changes in Clinical Characteristics of Patients with an Initial Diagnosis of Prostate Cancer in Korea: 10-Year Trends Reported by a Tertiary Center.

机构信息

Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

出版信息

J Korean Med Sci. 2018 Feb 5;33(6):e42. doi: 10.3346/jkms.2018.33.e42.

DOI:10.3346/jkms.2018.33.e42
PMID:29349937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5777916/
Abstract

BACKGROUND

The Korea Central Cancer Registry reported that incidence rates of prostate cancer have not increased continuously. We used recent trends in the incidence of prostate cancer to generate a preliminary report of the Korean population with prostate cancer.

METHODS

Patients initially diagnosed with prostate cancer by prostate biopsy from 2006 to 2015 at our tertiary center were selected. All patients were categorized according to age (< 65, 65-75, > 75 years), time period (2006-2010 vs. 2011-2015), and risk classification. Patients with insufficient data were excluded from the analysis.

RESULTS

Of 675 patients (median prostate-specific antigen [PSA], 9.09 ng/mL), those with a Gleason score (GS) of 6 (32.3%) comprised the largest proportion in our cohort. The proportion with a GS of 8 increased for those aged 65-75 years, despite the lack of increase in PSA. Treatment patterns changed for those with very low to low risk cancer. The overall survival (OS) rate and the cancer-specific survival (CSS) rate for all patients at 5 years were 87% and 90%, respectively. Patients with a low body mass index (BMI; ≤ 23 kg/m²) had worse median OS and CSS rates.

CONCLUSION

Significant differences in risk classifications and initial treatments were found between 2006-2010 and 2011-2015. Although PSA did not change, the GS did change. Lower BMI (≤ 23 kg/m²) had worse effects on OS and CSS rates for Korean prostate cancer patients.

摘要

背景

韩国中央癌症登记处报告称,前列腺癌的发病率并未持续增加。我们利用前列腺癌发病率的最新趋势,初步报告了韩国前列腺癌患者的情况。

方法

我们选择了 2006 年至 2015 年期间在我们的三级中心通过前列腺活检首次诊断为前列腺癌的患者。所有患者均根据年龄(<65 岁、65-75 岁、>75 岁)、时间段(2006-2010 年与 2011-2015 年)和危险度分类进行分类。未纳入分析的患者数据不足。

结果

在 675 名患者(中位前列腺特异性抗原 [PSA],9.09ng/ml)中,GS 为 6 分(32.3%)的患者构成了我们队列中的最大比例。对于 65-75 岁的患者,尽管 PSA 没有增加,但 GS 为 8 分的比例有所增加。对于低危和中危癌症患者,治疗模式发生了变化。所有患者的 5 年总生存率(OS)和癌症特异性生存率(CSS)分别为 87%和 90%。身体质量指数(BMI;≤23kg/m²)较低的患者中位 OS 和 CSS 率较差。

结论

在 2006-2010 年和 2011-2015 年之间,风险分类和初始治疗存在显著差异。尽管 PSA 没有变化,但 GS 发生了变化。BMI(≤23kg/m²)较低会对韩国前列腺癌患者的 OS 和 CSS 率产生更不利的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329b/5777916/28be1eebe1f3/jkms-33-e42-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329b/5777916/28be1eebe1f3/jkms-33-e42-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329b/5777916/28be1eebe1f3/jkms-33-e42-g001.jpg

相似文献

1
Changes in Clinical Characteristics of Patients with an Initial Diagnosis of Prostate Cancer in Korea: 10-Year Trends Reported by a Tertiary Center.韩国首次诊断为前列腺癌患者的临床特征变化:一家三级中心报告的 10 年趋势。
J Korean Med Sci. 2018 Feb 5;33(6):e42. doi: 10.3346/jkms.2018.33.e42.
2
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.根治性前列腺切除术是治疗标本中存在高病理 Gleason 评分前列腺癌的有效方法。
BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x. Epub 2012 Apr 4.
3
Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL.前列腺特异性抗原(PSA)值超过100 ng/mL的男性患者。
BJU Int. 2016 Apr;117 Suppl 4:68-75. doi: 10.1111/bju.13411. Epub 2016 Feb 18.
4
High-risk prostate cancer with Gleason score 8-10 and PSA level ≤15 ng/mL treated with permanent interstitial brachytherapy.高危前列腺癌,Gleason 评分 8-10 且 PSA 水平≤15ng/mL,采用永久性间质近距离放疗治疗。
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):992-6. doi: 10.1016/j.ijrobp.2010.07.006. Epub 2010 Oct 6.
5
The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort.风险因素的数量是前列腺癌死亡率的最强预测指标:极高风险前列腺癌队列的多机构研究结果。
Clin Transl Oncol. 2016 Oct;18(10):1026-33. doi: 10.1007/s12094-016-1481-5. Epub 2016 Jan 19.
6
Stage at presentation and survival outcomes of patients with Gleason 8-10 prostate cancer and low prostate-specific antigen.Gleason评分8-10且前列腺特异性抗原水平低的前列腺癌患者的就诊分期及生存结局
Urol Oncol. 2016 Mar;34(3):119.e19-26. doi: 10.1016/j.urolonc.2015.09.014. Epub 2015 Oct 29.
7
External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.临床分期为T1-2期前列腺癌的体外放射治疗与根治性前列腺切除术:根据治疗前前列腺特异性抗原(PSA)水平和活检Gleason评分分层的治疗意义
Cancer J Sci Am. 1997 Mar-Apr;3(2):78-87.
8
Low Serum Testosterone But Not Obesity Predicts High Gleason Score at Biopsy Diagnosed as Prostate Cancer in Patients with Serum PSA Lower than 20 ng/ml.血清前列腺特异抗原(PSA)低于20 ng/ml的前列腺癌患者活检时,低血清睾酮而非肥胖可预测高Gleason评分。
Anticancer Res. 2015 Nov;35(11):6137-45.
9
New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.新的前列腺癌分级系统可预测 Gleason 评分 8-10 级前列腺癌手术后的长期生存情况。
Eur Urol. 2017 Jun;71(6):907-912. doi: 10.1016/j.eururo.2016.11.006. Epub 2016 Nov 19.
10
The uncertain relationship between obesity and prostate cancer: an Italian biopsy cohort analysis.肥胖与前列腺癌之间不确定的关系:一项义大利前列腺活检队列分析。
Eur J Surg Oncol. 2011 Dec;37(12):1025-9. doi: 10.1016/j.ejso.2011.09.036. Epub 2011 Oct 1.

引用本文的文献

1
Clinicopathological features, treatment and outcome of Omani patients with localised prostate cancer.阿曼局部前列腺癌患者的临床病理特征、治疗及预后
Arab J Urol. 2020 Jul 6;18(4):219-225. doi: 10.1080/2090598X.2020.1781386.
2
High mortality risk of prostate cancer patients in Asia and West Africa: A systematic review.亚洲和西非前列腺癌患者的高死亡风险:一项系统综述。
Avicenna J Med. 2020 Jul 3;10(3):93-101. doi: 10.4103/ajm.ajm_19_20. eCollection 2020 Jul-Sep.
3
Does the Time Interval from Biopsy to Radical Prostatectomy Affect the Postoperative Oncologic Outcomes in Korean Men?

本文引用的文献

1
The Diagnosis and Treatment of Prostate Cancer: A Review.前列腺癌的诊断与治疗:综述
JAMA. 2017 Jun 27;317(24):2532-2542. doi: 10.1001/jama.2017.7248.
2
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014.韩国癌症统计数据:2014年的发病率、死亡率、生存率及患病率
Cancer Res Treat. 2017 Apr;49(2):292-305. doi: 10.4143/crt.2017.118. Epub 2017 Mar 9.
3
Cancer Statistics, 2017.《2017 年癌症统计》
从前列腺活检到根治性前列腺切除术的时间间隔是否会影响韩国男性的术后肿瘤学结果?
J Korean Med Sci. 2019 Sep 30;34(37):e234. doi: 10.3346/jkms.2019.34.e234.
4
Effects of Progressive Resistance Training on Post-Surgery Incontinence in Men with Prostate Cancer.渐进性抗阻训练对前列腺癌男性术后尿失禁的影响。
J Clin Med. 2018 Sep 19;7(9):292. doi: 10.3390/jcm7090292.
5
Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean men.非酒精性脂肪性肝病与前列腺癌的发展有关吗?一项针对 10516985 名韩国男性的全国性研究。
PLoS One. 2018 Sep 19;13(9):e0201308. doi: 10.1371/journal.pone.0201308. eCollection 2018.
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
4
Obesity and Other Cancers.肥胖与其他癌症。
J Clin Oncol. 2016 Dec 10;34(35):4231-4237. doi: 10.1200/JCO.2016.68.4837. Epub 2016 Nov 7.
5
Clinical characteristics and primary management of patients diagnosed with prostate cancer between 2007 and 2013: status from a Danish primary referral center.2007年至2013年间确诊为前列腺癌患者的临床特征及初步治疗:来自丹麦一家初级转诊中心的情况
Acta Oncol. 2016 Dec;55(12):1456-1460. doi: 10.1080/0284186X.2016.1191667. Epub 2016 Jun 22.
6
The incidence and mortality of prostate cancer and its relationship with development in Asia.亚洲地区前列腺癌的发病率和死亡率及其与发展的关系。
Prostate Int. 2015 Dec;3(4):135-40. doi: 10.1016/j.prnil.2015.09.001. Epub 2015 Sep 25.
7
Prostate Cancer, Version 1.2016.前列腺癌临床实践指南(2016 年版)
J Natl Compr Canc Netw. 2016 Jan;14(1):19-30. doi: 10.6004/jnccn.2016.0004.
8
Exercise for Men with Prostate Cancer: A Systematic Review and Meta-analysis.前列腺癌男性的运动:系统评价与荟萃分析
Eur Urol. 2016 Apr;69(4):693-703. doi: 10.1016/j.eururo.2015.10.047. Epub 2015 Nov 26.
9
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.2014年国际泌尿病理学会(ISUP)前列腺癌Gleason分级共识会议:分级模式的定义及新分级系统的建议
Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530.
10
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.